Opioid receptors and opioid peptide-producing leukocytes in inflammatory pain - Basic and therapeutic aspects

Brain, Behavior, and Immunity

Volumn 24, Issue 5, 2010, Pages 683-694

  Busch Dienstfertig, Melanie ^a   Stein, Christoph ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Inflammation; Nociception; Opioid peptides; Opioid receptors; Peripheral analgesia

Indexed keywords

17 METHYLNALOXONE; ACETAMIDE DERIVATIVE; ADENOSINE A1 RECEPTOR AGONIST; ADL 10 0101; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ARYLACETAMIDE; ASIMADOLINE; CR 665; CYCLOSPORIN A; DELTA OPIATE RECEPTOR AGONIST; FE 200665; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; KAPPA OPIATE RECEPTOR AGONIST; LIGAND; LOPERAMIDE; MORPHINE; MU OPIATE RECEPTOR AGONIST; NALFURAFINE; NALOXONE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OPIATE ANTAGONIST; OPIATE PEPTIDE; OPIATE RECEPTOR; SELECTIN ANTAGONIST; UNCLASSIFIED DRUG;

ADDICTION; ALLODYNIA; BLEEDING; BLOOD BRAIN BARRIER; BRAIN; DIARRHEA; DYSPHORIA; EXCITATION; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INFLAMMATORY CELL; LEUKOCYTE; NAUSEA; NEPHROTOXICITY; NERVE FUNCTION; NOCICEPTION; NONHUMAN; PAIN; PLASTICITY; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; SENSITIZATION; SENSORY NERVE; SIGNAL TRANSDUCTION; SPINAL CORD; STOMACH EROSION; STOMACH ULCER; THROMBOEMBOLISM; TISSUE INJURY;

ANIMALS; HUMANS; INFLAMMATION; LEUKOCYTES; NEURONS; OPIOID PEPTIDES; PAIN; RECEPTORS, OPIOID; SIGNAL TRANSDUCTION;

EID: 77953619984     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2009.10.013     Document Type: Review

References (219)

1. Akins P.T., McCleskey E.W. Characterization of potassium currents in adult rat sensory neurons and modulation by opioids and cyclic AMP. Neuroscience 1993, 56:759-769.
2. American Society of Anesthesiologists Task Force, 2004. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 100, 1573-1581.
3. Antonijevic I., Mousa S.A., Schäfer M., Stein C. Perineurial defect and peripheral opioid analgesia in inflammation. J. Neurosci. 1995, 15:165-172.
4. Azad S.C., Beyer A., Romer A.W., Galle-Rod A., Peter K., Schops P. Continuous axillary brachial plexus analgesia with low dose morphine in patients with complex regional pain syndromes. Eur. J. Anaesthesiol. 2000, 17:185-188.
5. Baamonde A., Lastra A., Juarez L., Garcia V., Hidalgo A., Menendez L. Effects of the local administration of selective mu-, delta-and kappa-opioid receptor agonists on osteosarcoma-induced hyperalgesia. Naunyn Schmiedebergs Arch. Pharmacol. 2005, 372:213-219.
6. Baamonde A., Lastra A., Juarez L., Garcia-Suarez O., Meana A., Hidalgo A., Menendez L. Endogenous beta-endorphin induces thermal analgesia at the initial stages of a murine osteosarcoma. Peptides 2006, 27:2778-2785.
7. Ballet S., Conrath M., Fischer J., Kaneko T., Hamon M., Cesselin F. Expression and G-protein coupling of mu-opioid receptors in the spinal cord and dorsal root ganglia of polyarthritic rats. Neuropeptides 2003, 37:211-219.
8. Bartho L., Stein C., Herz A. Involvement of capsaicin-sensitive neurones in hyperalgesia and enhanced opioid antinociception in inflammation. Naunyn Schmiedebergs Arch. Pharmacol. 1990, 342:666-670.
9. Berg K.A., Patwardhan A.M., Sanchez T.A., Silva Y.M., Hargreaves K.M., Clarke W.P. Rapid modulation of micro-opioid receptor signaling in primary sensory neurons. J. Pharmacol. Exp. Ther. 2007, 321:839-847.
10. Berg K.A., Zardeneta G., Hargreaves K.M., Clarke W.P., Milam S.B. Integrins regulate opioid receptor signaling in trigeminal ganglion neurons. Neuroscience 2007, 144:889-897.
11. Bergstrom J., Ahmed M., Li J., Ahmad T., Kreicbergs A., Spetea M. Opioid peptides and receptors in joint tissues: study in the rat. J. Orthop. Res. 2006, 24:1193-1199.
12. Beutler A.S., Banck M.S., Walsh C.E., Milligan E.D. Intrathecal gene transfer by adeno-associated virus for pain. Curr. Opin. Mol. Ther. 2005, 7:431-439.
13. Bileviciute-Ljungar I., Spetea M., Guo Y., Schutz J., Windisch P., Schmidhammer H. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4, 5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)am ino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation. J. Pharmacol. Exp. Ther. 2006, 317:220-227.
14. Binder W., Mousa S.A., Sitte N., Kaiser M., Stein C., Schäfer M. Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue. J. Eur. Neurosci. 2004, 20:92-100.
15. Blalock J.E., Smith E.M. Human leukocyte interferon: structural and biological relatedness to adrenocorticotropic hormone and endorphins. Proc. Natl. Acad. Sci. USA 1980, 77:5972-5974.
16. Bong G.W., Rosengren S., Firestein G.S. Spinal cord adenosine receptor stimulation in rats inhibits peripheral neutrophil accumulation. The role of N-methyl-d-aspartate receptors. J. Clin. Invest. 1996, 98:2779-2785.
17. Brack C., Nagata S., Mantei N., Weissmann C. Molecular analysis of the human interferon-alpha gene family. Gene 1981, 15:379-394.
18. Brack A., Labuz D., Schiltz A., Rittner H.L., Machelska H., Schäfer M., Reszka R., Stein C. Tissue monocytes/macrophages in inflammation: hyperalgesia versus opioid-mediated peripheral antinociception. Anesthesiology 2004, 101:204-211.
19. Brack A., Rittner H.L., Machelska H., Beschmann K., Sitte N., Schäfer M., Stein C. Mobilization of opioid-containing polymorphonuclear cells by hematopoietic growth factors and influence on inflammatory pain. Anesthesiology 2004, 100:149-157.
20. Brack A., Rittner H.L., Machelska H., Leder K., Mousa S.A., Schäfer M., Stein C. Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells. Pain 2004, 112:229-238.
21. Brower V. New paths to pain relief. Nat. Biotechnol. 2000, 18:387-391.
22. Buzas B., Cox B.M. Quantitative analysis of mu and delta opioid receptor gene expression in rat brain and peripheral ganglia using competitive polymerase chain reaction. Neuroscience 1997, 76:479-489.
23. Buzzetti R., McLoughlin L., Lavender P.M., Clark A.J., Rees L.H. Expression of pro-opiomelanocortin gene and quantification of adrenocorticotropic hormone-like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies. J. Clin. Invest. 1989, 83:733-737.
24. Cabot P.J., Carter L., Gaiddon C., Zhang Q., Schäfer M., Loeffler J.P., Stein C. Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats. J. Clin. Invest. 1997, 100:142-148.
25. Cabot P.J., Carter L., Schäfer M., Stein C. Methionine-enkephalin-and dynorphin A-release from immune cells and control of inflammatory pain. Pain 2001, 93:207-212.
26. Calza L., Pozza M., Zanni M., Manzini C.U., Manzini E., Hokfelt T. Peptide plasticity in primary sensory neurons and spinal cord during adjuvant-induced arthritis in the rat: an immunocytochemical and in situ hybridization study. Neuroscience 1998, 82:575-589.
27. Carlton S.M., Coggeshall R.E. Immunohistochemical localization of enkephalin in peripheral sensory axons in the rat. Neurosci. Lett. 1997, 221:121-124.
28. Chadzinska M., Maj M., Scislowska-Czarnecka A., Przewlocka B., Plytycz B. Expression of proenkephalin (PENK) mRNA in inflammatory leukocytes during experimental peritonitis in Swiss mice. Pol. J. Pharmacol. 2001, 53:715-718.
29. Chadzinska M., Starowicz K., Scislowska-Czarnecka A., Bilecki W., Pierzchala-Koziec K., Przewlocki R., Przewlocka B., Plytycz B. Morphine-induced changes in the activity of proopiomelanocortin and prodynorphin systems in zymosan-induced peritonitis in mice. Immunol. Lett. 2005, 101:185-192.
30. Chakass D., Philippe D., Erdual E., Dharancy S., Malapel M., Dubuquoy C., Thuru X., Gay J., Gaveriaux-Ruff C., Dubus P., Mathurin P., Kieffer B.L., Desreumaux P., Chamaillard M. Micro-opioid receptor activation prevents acute hepatic inflammation and cell death. Gut 2007, 56:974-981.
31. Chen J.J., Dymshitz J., Vasko M.R. Regulation of opioid receptors in rat sensory neurons in culture. Mol. Pharmacol. 1997, 51:666-673.
32. Chizhmakov I., Yudin Y., Mamenko N., Prudnikov I., Tamarova Z., Krishtal O. Opioids inhibit purinergic nociceptors in the sensory neurons and fibres of rat via a G protein-dependent mechanism. Neuropharmacology 2005, 48:639-647.
33. Clark A.J., Lavender P.M., Coates P., Johnson M.R., Rees L.H. In vitro and in vivo analysis of the processing and fate of the peptide products of the short proopiomelanocortin mRNA. Mol. Endocrinol. 1990, 4:1737-1743.
34. Coggeshall R.E., Zhou S., Carlton S.M. Opioid receptors on peripheral sensory axons. Brain Res. 1997, 764:126-132.
35. Cool D.R., Loh Y.P. Identification of a sorting signal for the regulated secretory pathway at the N-terminus of pro-opiomelanocortin. Biochimie 1994, 76:265-270.
36. Craft R.M., Henley S.R., Haaseth R.C., Hruby V.J., Porreca F. Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration. J. Pharmacol. Exp. Ther. 1995, 275:1535-1542.
37. Crowe R., Parkhouse N., McGrouther D., Burnstock G. Neuropeptide-containing nerves in painful hypertrophic human scar tissue. Br. J. Dermatol. 1994, 130:444-452.
38. Cunha F.Q., Ferreira S.H. Peripheral hyperalgesic cytokines. Adv. Exp. Med. Biol. 2003, 521:22-39.
39. Czlonkowski A., Stein C., Herz A. Peripheral mechanisms of opioid antinociception in inflammation: involvement of cytokines. Eur. J. Pharmacol. 1993, 242:229-235.
40. DeBold C.R., Nicholson W.E., Orth D.N. Immunoreactive proopiomelanocortin (POMC) peptides and POMC-like messenger ribonucleic acid are present in many rat nonpituitary tissues. Endocrinology 1988, 122:2648-2657.
41. DeHaven-Hudkins D.L., Dolle R.E. Peripherally restricted opioid agonists as novel analgesic agents. Curr. Pharm. Des. 2004, 10:743-757.
42. Dionne R.A., Lepinski A.M., Gordon S.M., Jaber L., Brahim J.S., Hargreaves K.M. Analgesic effects of peripherally administered opioids in clinical models of acute and chronic inflammation. Clin. Pharmacol. Ther. 2001, 70:66-73.
43. Drouin J., Chamberland M., Charron J., Jeannotte L., Nemer M. Structure of the rat pro-opiomelanocortin (POMC) gene. FEBS Lett. 1985, 193:54-58.
44. Eiden L.E. The enkephalin-containing cell: strategies for polypeptide synthesis and secretion throughout the neuroendocrine system. Cell. Mol. Neurobiol. 1987, 7:339-352.
45. Eisenach J.C., Carpenter R., Curry R. Analgesia from a peripherally active kappa-opioid receptor agonist in patients with chronic pancreatitis. Pain 2003, 101:89-95.
46. Eisinger D.A., Ammer H., Schulz R. Chronic morphine treatment inhibits opioid receptor desensitization and internalization. J. Neurosci. 2002, 22:10192-10200.
47. Endres-Becker J., Heppenstall P.A., Mousa S.A., Labuz D., Oksche A., Schäfer M., Stein C., Zöllner C. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain. Mol. Pharmacol. 2007, 71:12-18.
48. Evans C.J., Keith D.E., Morrison H., Magendzo K., Edwards R.H. Cloning of a delta opioid receptor by functional expression. Science 1992, 258:1952-1955.
49. Fichna J., Janecka A., Costentin J., Do Rego J.C. The endomorphin system and its evolving neurophysiological role. Pharmacol. Rev. 2007, 59:88-123.
50. Fürst S., Riba P., Friedmann T., Timar J., Al-Khrasani M., Obara I., Makuch W., Spetea M., Schutz J., Przewlocki R., Przewlocka B., Schmidhammer H. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat. J. Pharmacol. Exp. Ther. 2005, 312:609-618.
51. Galin F.S., LeBoeuf R.D., Blalock J.E. Corticotropin-releasing factor upregulates expression of two truncated pro-opiomelanocortin transcripts in murine lymphocytes. J. Neuroimmunol. 1991, 31:51-58.
52. Gendron L., Lucido A.L., Mennicken F., O'Donnell D., Vincent J.P., Stroh T., Beaudet A. Morphine and pain-related stimuli enhance cell surface availability of somatic delta-opioid receptors in rat dorsal root ganglia. J. Neurosci. 2006, 26:953-962.
53. Gibbins I.L., Furness J.B., Costa M. Pathway-specific patterns of the co-existence of substance P, calcitonin gene-related peptide, cholecystokinin and dynorphin in neurons of the dorsal root ganglia of the guinea-pig. Cell Tissue Res. 1987, 248:417-437.
54. + current in rat sensory neurons in vitro. Neurosci. Lett. 1996, 212:83-86.
55. Guan Y., Johanek L.M., Hartke T.V., Shim B., Tao Y.X., Ringkamp M., Meyer R.A., Raja S.N. Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury. Pain 2008, 138:318-329.
56. Hanna M.H., Elliott K.M., Fung M. Randomized, double-blind study of the analgesic efficacy of morphine-6-glucuronide versus morphine sulfate for postoperative pain in major surgery. Anesthesiology 2005, 102:815-821.
57. Hargreaves K.M., Dubner R., Costello A.H. Corticotropin releasing factor (CRF) has a peripheral site of action for antinociception. Eur. J. Pharmacol. 1989, 170:275-279.
58. Hassan A.H., Ableitner A., Stein C., Herz A. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience 1993, 55:185-195.
59. 2+ channels by G-protein beta gamma subunits. Nature 1996, 380:258-262.
60. Hermanussen S., Do M., Cabot P.J. Reduction of beta-endorphin-containing immune cells in inflamed paw tissue corresponds with a reduction in immune-derived antinociception: reversible by donor activated lymphocytes. Anesth. Analg. 2004, 98:723-729.
61. Heurich M., Mousa S.A., Lenzner M., Morciniec P., Kopf A., Welte M., Stein C. Influence of pain treatment by epidural fentanyl and bupivacaine on homing of opioid-containing leukocytes to surgical wounds. Brain Behav. Immun. 2007, 21:544-552.
62. Hook S., Camberis M., Prout M., Konig M., Zimmer A., Van Heeke G., Le Gros G. Preproenkephalin is a Th2 cytokine but is not required for Th2 differentiation in vitro. Immunol. Cell Biol. 1999, 77:385-390.
63. Hua S., Hermanussen S., Tang L., Monteith G.R., Cabot P.J. The neural cell adhesion molecule antibody blocks cold water swim stress-induced analgesia and cell adhesion between lymphocytes and cultured dorsal root ganglion neurons. Anesth. Analg. 2006, 103:1558-1564.
64. Ibrahim M.M., Porreca F., Lai J., Albrecht P.J., Rice F.L., Khodorova A., Davar G., Makriyannis A., Vanderah T.W., Mata H.P., Malan T.P. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc. Natl. Acad. Sci. USA 2005, 102:3093-3098.
65. Ingram S.L., Williams J.T. Opioid inhibition of Ih via adenylyl cyclase. Neuron 1994, 13:179-186.
66. Jaber L., Swaim W.D., Dionne R.A. Immunohistochemical localization of mu-opioid receptors in human dental pulp. J. Endod. 2003, 29:108-110.
67. Jeanjean A.P., Moussaoui S.M., Maloteaux J.M., Laduron P.M. Interleukin-1 beta induces long-term increase of axonally transported opiate receptors and substance P. Neuroscience 1995, 68:151-157.
68. Ji R.R., Zhang Q., Law P.Y., Low H.H., Elde R., Hokfelt T. Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J. Neurosci. 1995, 15:8156-8166.
69. Joshi J.B., Dave H.P. Transactivation of the proenkephalin gene promoter by the Tax1 protein of human T-cell lymphotropic virus type I. Proc. Natl. Acad. Sci. USA 1992, 89:1006-1010.
70. Junger H., Moore A.C., Sorkin L.S. Effects of full-thickness burns on nociceptor sensitization in anesthetized rats. Burns 2002, 28:772-777.
71. Kabli N., Cahill C.M. Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain. Pain 2007, 127:84-93.
72. Kalso E., Smith L., McQuay H.J., Andrew Moore R. No pain, no gain: clinical excellence and scientific rigour - lessons learned from IA morphine. Pain 2002, 98:269-275.
73. Kamphuis S., Kavelaars A., Brooimans R., Kuis W., Zegers B.J., Heijnen C.J. T helper 2 cytokines induce preproenkephalin mRNA expression and proenkephalin A in human peripheral blood mononuclear cells. J. Neuroimmunol. 1997, 79:91-99.
74. Kavelaars A., Ballieux R.E., Heijnen C.J. In vitro beta-adrenergic stimulation of lymphocytes induces the release of immunoreactive beta-endorphin. Endocrinology 1990, 126:3028-3032.
75. Khasabova I.A., Harding-Rose C., Simone D.A., Seybold V.S. Differential effects of CB1 and opioid agonists on two populations of adult rat dorsal root ganglion neurons. J. Neurosci. 2004, 24:1744-1753.
76. Khodorova A., Navarro B., Jouaville L.S., Murphy J.E., Rice F.L., Mazurkiewicz J.E., Long-Woodward D., Stoffel M., Strichartz G.R., Yukhananov R., Davar G. Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury. Nat. Med. 2003, 9:1055-1061. (Epub 2003 Jun 1029).
77. Kieffer B.L., Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 2002, 66:285-306.
78. Kieffer B.L., Befort K., Gaveriaux-Ruff C., Hirth C.G. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 1992, 89:12048-12052.
79. Kita T., Inoue A., Nakanishi S., Numa S. Purification and characterization of the messenger RNA coding for bovine corticotropin/beta-lipotropin precursor. Eur. J. Biochem. 1979, 93:213-220.
80. Koch T., Widera A., Bartzsch K., Schulz S., Brandenburg L.O., Wundrack N., Beyer A., Grecksch G., Hollt V. Receptor endocytosis counteracts the development of opioid tolerance. Mol. Pharmacol. 2005, 67:280-287.
81. Kondo I., Marvizon J.C., Song B., Salgado F., Codeluppi S., Hua X.Y., Yaksh T.L. Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release. J. Neurosci. 2005, 25:3651-3660.
82. Kopf A., Schmidt S., Stein C. Topical administration of analgesics. Textbook of Palliative Medicine 2006, 450-457. Hodder Arnold, London. E. Bruera, I.J. Higginson, C. Ripamonti, C.F. von Gunten (Eds.).
83. Kraus J., Borner C., Giannini E., Hickfang K., Braun H., Mayer P., Hoehe M.R., Ambrosch A., Konig W., Hollt V. Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J. Biol. Chem. 2001, 276:43901-43908. (Epub 42001 Sep 43925).
84. Kyrkanides S., Fiorentino P.M., Miller J.N., Gan Y., Lai Y.C., Shaftel S.S., Puzas J.E., Piancino M.G., O'Banion M.K., Tallents R.H. Amelioration of pain and histopathologic joint abnormalities in the Col1-IL-1beta(XAT) mouse model of arthritis by intraarticular induction of mu-opioid receptor into the temporomandibular joint. Arthritis Rheum. 2007, 56:2038-2048.
85. Labuz D., Berger S., Mousa S.A., Zöllner C., Rittner H.L., Shaqura M.A., Segovia-Silvestre T., Przewlocka B., Stein C., Machelska H. Peripheral antinociceptive effects of exogenous and immune cell-derived endomorphins in prolonged inflammatory pain. J. Neurosci. 2006, 26:4350-4358.
86. Labuz D., Mousa S.A., Schäfer M., Stein C., Machelska H. Relative contribution of peripheral versus central opioid receptors to antinociception. Brain Res. 2007, 1160:30-38.
87. Labuz D., Schmidt Y., Schreiter A., Rittner H.L., Mousa S.A., Machelska H. Immune cell-derived opioids protect against neuropathic pain in mice. J. Clin. Invest. 2009, 119:278-286.
88. Lacaze-Masmonteil T., de Keyzer Y., Luton J.P., Kahn A., Bertagna X. Characterization of proopiomelanocortin transcripts in human nonpituitary tissues. Proc. Natl. Acad. Sci. USA 1987, 84:7261-7265.
89. LaMendola J., Martin S.K., Steiner D.F. Expression of PC3, carboxypeptidase E and enkephalin in human monocyte-derived macrophages as a tool for genetic studies. FEBS Lett. 1997, 404:19-22.
90. Lang L.J., Stein C. Peripheral mechanisms of opioid analgesia. Curr. Opin. Pharmacol. 2009, 9:3-8.
91. Law P.Y., Wong Y.H., Loh H.H. Molecular mechanisms and regulation of opioid receptor signaling. Annu. Rev. Pharmacol. Toxicol. 2000, 40:389-430.
92. Lewanowitsch T., Irvine R.J. Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal. Eur. J. Pharmacol. 2002, 445:61-67.
93. Li J.L., Kaneko T., Mizuno N. Effects of peripheral nerve ligation on expression of mu-opioid receptor in sensory ganglion neurons: an immunohistochemical study in dorsal root and nodose ganglion neurons of the rat. Neurosci. Lett. 1996, 214:91-94.
94. Li J.L., Ding Y.Q., Li Y.Q., Li J.S., Nomura S., Kaneko T., Mizuno N. Immunocytochemical localization of mu-opioid receptor in primary afferent neurons containing substance P or calcitonin gene-related peptide. A light and electron microscope study in the rat. Brain Res. 1998, 794:347-352.
95. Likar R., Schäfer M., Paulak F., Sittl R., Pipam W., Schalk H., Geissler D., Bernatzky G. Intraarticular morphine analgesia in chronic pain patients with osteoarthritis. Anesth. Analg. 1997, 84:1313-1317.
96. Likar R., Mousa S.A., Philippitsch G., Steinkellner H., Koppert W., Stein C., Schäfer M. Increased numbers of opioid expressing inflammatory cells do not affect intra-articular morphine analgesia. Br. J. Anaesth. 2004, 93:375-380.
97. Likar R., Mousa S.A., Steinkellner H., Koppert W., Philippitsch G., Stein C., Schäfer M. Involvement of intra-articular corticotropin-releasing hormone in postoperative pain modulation. Clin. J. Pain 2007, 23:136-142.
98. Linner K.M., Beyer H.S., Sharp B.M. Induction of the messenger ribonucleic acid for proenkephalin A in cultured murine CD4-positive thymocytes. Endocrinology 1991, 128:717-724.
99. Linner K.M., Quist H.E., Sharp B.M. Expression and function of proenkephalin A messenger ribonucleic acid in murine fetal thymocytes. Endocrinology 1996, 137:857-863.
100. Lolait S.J., Clements J.A., Markwick A.J., Cheng C., McNally M., Smith A.I., Funder J.W. Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages. J. Clin. Invest. 1986, 77:1776-1779.
101. Lyons P.D., Blalock J.E. Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes. J. Neuroimmunol. 1997, 78:47-56.
102. Machelska H. Targeting of opioid-producing leukocytes for pain control. Neuropeptides 2007, 41:355-363.
103. Machelska H., Cabot P.J., Mousa S.A., Zhang Q., Stein C. Pain control in inflammation governed by selectins. Nat. Med. 1998, 4:1425-1428.
104. Machelska H., Pfluger M., Weber W., Piranvisseh-Volk M., Daubert J.D., Dehaven R., Stein C. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans. J. Pharmacol. Exp. Ther. 1999, 290:354-361.
105. Machelska H., Mousa S.A., Brack A., Schopohl J.K., Rittner H.L., Schäfer M., Stein C. Opioid control of inflammatory pain regulated by intercellular adhesion molecule-1. J. Neurosci. 2002, 22:5588-5596.
106. Machelska H., Schopohl J.K., Mousa S.A., Labuz D., Schäfer M., Stein C. Different mechanisms of intrinsic pain inhibition in early and late inflammation. J. Neuroimmunol. 2003, 141:30-39.
107. Machelska H., Brack A., Mousa S.A., Schopohl J.K., Rittner H.L., Schäfer M., Stein C. Selectins and integrins but not platelet-endothelial cell adhesion molecule-1 regulate opioid inhibition of inflammatory pain. Br. J. Pharmacol. 2004, 142:772-780.
108. Maier C.C., Blalock J.E. PCR-based cloning, sequencing, and exon mapping of lymphocyte-derived neuroendocrine peptides. Immunomethods 1994, 5:3-7.
109. Mangel A.W., Bornstein J.D., Hamm L.R., Buda J., Wang J., Irish W., Urso D. Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome. Aliment. Pharmacol. Ther. 2008, 28:239-249.
110. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., Watson S.J. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J. Comp. Neurol. 1994, 350:412-438.
111. Martin-Schild S., Gerall A.A., Kastin A.J., Zadina J.E. Endomorphin-2 is an endogenous opioid in primary sensory afferent fibers. Peptides 1998, 19:1783-1789.
112. Mata M., Glorioso J.C., Fink D.J. Targeted gene delivery to the nervous system using herpes simplex virus vectors. Physiol. Behav. 2002, 77:483-488.
113. Meng F., Xie G.X., Thompson R.C., Mansour A., Goldstein A., Watson S.J., Akil H. Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc. Natl. Acad. Sci. USA 1993, 90:9954-9958.
114. Minami M., Maekawa K., Yabuuchi K., Satoh M. Double in situ hybridization study on coexistence of mu-, delta- and kappa-opioid receptor mRNAs with preprotachykinin A mRNA in the rat dorsal root ganglia. Brain Res. Mol. Brain Res. 1995, 30:203-210.
115. Mousa S.A., Schäfer M., Mitchell W.M., Hassan A.H., Stein C. Local upregulation of corticotropin-releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation. Eur. J. Pharmacol. 1996, 311:221-231.
116. Mousa S.A., Machelska H., Schäfer M., Stein C. Co-expression of beta-endorphin with adhesion molecules in a model of inflammatory pain. J. Neuroimmunol. 2000, 108:160-170.
117. Mousa S.A., Zhang Q., Sitte N., Ji R., Stein C. Beta-Endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J. Neuroimmunol. 2001, 115:71-78.
118. Mousa S.A., Machelska H., Schäfer M., Stein C. Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain. J. Neuroimmunol. 2002, 126:5-15.
119. Mousa S.A., Bopaiah C.P., Stein C., Schäfer M. Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain. Pain 2003, 106:297-307.
120. Mousa S.A., Shakibaei M., Sitte N., Schäfer M., Stein C. Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology 2004, 145:1331-1341.
121. Mousa S.A., Cheppudira B.P., Shaqura M., Fischer O., Hofmann J., Hellweg R., Schäfer M. Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain. Brain 2007, 130:502-513.
122. Mousa S.A., Straub R.H., Schäfer M., Stein C. Beta-endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis. Ann. Rheum. Dis. 2007, 66:871-879.
123. Nagata S., Mantei N., Weissmann C. The structure of one of the eight or more distinct chromosomal genes for human interferon-alpha. Nature 1980, 287:401-408.
124. Nakanishi S., Inoue A., Kita T., Nakamura M., Chang A.C., Cohen S.N., Numa S. Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor. Nature 1979, 278:423-427.
125. Oates E., Herbert E. 5' sequence of porcine and rat pro-opiomelanocortin mRNA. One porcine and two rat forms. J. Biol. Chem. 1984, 259:7421-7425.
126. Oates E.L., Allaway G.P., Armstrong G.R., Boyajian R.A., Kehrl J.H., Prabhakar B.S. Human lymphocytes produce pro-opiomelanocortin gene-related transcripts. Effects of lymphotropic viruses. J. Biol. Chem. 1988, 263:10041-10044.
127. Obara I., Makuch W., Spetea M., Schutz J., Schmidhammer H., Przewlocki R., Przewlocka B. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat. Eur. J. Pharmacol. 2007, 558:60-67.
128. Oh S.B., Tran P.B., Gillard S.E., Hurley R.W., Hammond D.L., Miller R.J. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J. Neurosci. 2001, 21:5027-5035.
129. Ohta K., Shichiri M., Kameya T., Matsubara O., Imai T., Marumo F., Hirata Y. Thymic hyperplasia as a source of ectopic ACTH production. Endocr. J. 2000, 47:487-492.
130. Patwardhan A.M., Berg K.A., Akopain A.N., Jeske N.A., Gamper N., Clarke W.P., Hargreaves K.M. Bradykinin-induced functional competence and trafficking of the delta-opioid receptor in trigeminal nociceptors. J. Neurosci. 2005, 25:8825-8832.
131. Philippe D., Dubuquoy L., Groux H., Brun V., Chuoi-Mariot M.T., Gaveriaux-Ruff C., Colombel J.F., Kieffer B.L., Desreumaux P. Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation. J. Clin. Invest. 2003, 111:1329-1338.
132. Picard P.R., Tramer M.R., McQuay H.J., Moore R.A. Analgesic efficacy of peripheral opioids (all except intra-articular): a qualitative systematic review of randomised controlled trials. Pain 1997, 72:309-318.
133. Pierce T.L., Grahek M.D., Wessendorf M.W. Immunoreactivity for endomorphin-2 occurs in primary afferents in rats and monkey. Neuroreport 1998, 9:385-389.
134. Pohl M., Collin E., Bourgoin S., Conrath M., Benoliel J.J., Nevo I., Hamon M., Giraud P., Cesselin F. Expression of preproenkephalin A gene and presence of Met-enkephalin in dorsal root ganglia of the adult rat. J. Neurochem. 1994, 63:1226-1234.
135. Pohl M., Meunier A., Hamon M., Braz J. Gene therapy of chronic pain. Curr. Gene Ther. 2003, 3:223-238.
136. Pol O., Murtra P., Caracuel L., Valverde O., Puig M.M., Maldonado R. Expression of opioid receptors and c-fos in CB1 knockout mice exposed to neuropathic pain. Neuropharmacology 2006, 50:123-132.
137. Polydefkis M., Griffin J.W., McArthur J. New insights into diabetic polyneuropathy. JAMA 2003, 290:1371-1376.
138. Przewlocki R., Gramsch C., Pasi A., Herz A. Characterization and localization of immunoreactive dynorphin, alpha-neo-endorphin, Met-enkephalin and substance P in human spinal cord. Brain Res. 1983, 280:95-103.
139. Przewlocki R., Hassan A.H., Lason W., Epplen C., Herz A., Stein C. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience 1992, 48:491-500.
140. Puehler W., Zöllner C., Brack A., Shaqura M.A., Krause H., Schäfer M., Stein C. Rapid upregulation of mu opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction. Neuroscience 2004, 129:473-479.
141. Puehler W., Rittner H.L., Mousa S.A., Brack A., Krause H., Stein C., Schäfer M. Interleukin-1 beta contributes to the upregulation of kappa opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation. Neuroscience 2006, 141:989-998.
142. Quartu M., Del Fiacco M. Enkephalins occur and colocalize with substance P in human trigeminal ganglion neurones. NeuroReport 1994, 5:465-468.
143. Ramabadran K. Effects of N-methylnaloxone and N-methylnaltrexone on nociception and precipitated abstinence in mice. Life Sci. 1982, 31:1253-1256.
144. Ramabadran K., Suaudeau C., Jacob J.J. A comparison of some pharmacological effects of naloxone and N-methylnaloxone in mice. Can. J. Physiol. Pharmacol. 1982, 60:715-719.
145. Rasenick M.M., Childers S.R. Modification of Gs-stimulated adenylate cyclase in brain membranes by low pH pretreatment: correlation with altered guanine nucleotide exchange. J. Neurochem. 1989, 53:219-225.
146. Rashid M.H., Inoue M., Toda K., Ueda H. Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain. J. Pharmacol. Exp. Ther. 2004, 309:380-387.
147. Rattner A., Korner M., Rosen H., Baeuerle P.A., Citri Y. Nuclear factor kappa B activates proenkephalin transcription in T lymphocytes. Mol. Cell. Biol. 1991, 11:1017-1022.
148. Rau K.K., Caudle R.M., Cooper B.Y., Johnson R.D. Diverse immunocytochemical expression of opioid receptors in electrophysiologically defined cells of rat dorsal root ganglia. J. Chem. Neuroanat. 2005, 29:255-264.
149. Reichert J.A., Daughters R.S., Rivard R., Simone D.A. Peripheral and preemptive opioid antinociception in a mouse visceral pain model. Pain 2001, 89:221-227.
150. Rittner H.L., Brack A., Machelska H., Mousa S.A., Bauer M., Schäfer M., Stein C. Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. Anesthesiology 2001, 95:500-508.
151. 2+-regulated release of opioid peptides from polymorphonuclear cells. FASEB J. 2006, 20:2627-2629.
152. Rittner H.L., Mousa S.A., Labuz D., Beschmann K., Schäfer M., Stein C., Brack A. Selective local PMN recruitment by CXCL1 or CXCL2/3 injection does not cause inflammatory pain. J. Leukoc. Biol. 2006, 79:1022-1032.
153. Rittner H.L., Labuz D., Richter J.F., Brack A., Schäfer M., Stein C., Mousa S.A. CXCR1/2 ligands induce p38 MAPK-dependent translocation and release of opioid peptides from primary granules in vitro and in vivo. Brain Behav. Immun. 2007, 21:1021-1032.
154. Rittner H.L., Lux C., Labuz D., Mousa S.A., Schäfer M., Stein C., Brack A. Neurokinin-1 receptor antagonists inhibit the recruitment of opioid-containing leukocytes and impair peripheral antinociception. Anesthesiology 2007, 107:1009-1017.
155. Rittner H.L., Machelska H., Stein C. Immune system, pain and analgesia. The Senses: A Comprehensive Reference 2008, 407-427. Academic Press, San Diego. A.I. Basbaum, A. Kaneko, G.M. Shepherd, G. Westheimer (Eds.).
156. Rittner H.L., Hackel D., Voigt P., Mousa S., Stolz A., Labuz D., Schäfer M., Schaefer M., Stein C., Brack A. Mycobacteria attenuate nociceptive responses by formyl peptide receptor triggered opioid peptide release from neutrophils. PLoS Pathog. 2009, 5:e1000362.
157. Riviere P.J. Peripheral kappa-opioid agonists for visceral pain. Br. J. Pharmacol. 2004, 141:1331-1334.
158. Sawynok J. Topical and peripherally acting analgesics. Pharmacol. Rev. 2003, 55:1-20.
159. Schäfer M., Carter L., Stein C. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc. Natl. Acad. Sci. USA 1994, 91:4219-4223.
160. Schäfer M., Mousa S.A., Zhang Q., Carter L., Stein C. Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc. Natl. Acad. Sci. USA 1996, 93:6096-6100.
161. Schmitt T.K., Mousa S.A., Brack A., Schmidt D.K., Rittner H.L., Welte M., Schäfer M., Stein C. Modulation of peripheral endogenous opioid analgesia by central afferent blockade. Anesthesiology 2003, 98:195-202.
162. Schulz S., Mayer D., Pfeiffer M., Stumm R., Koch T., Hollt V. Morphine induces terminal micro-opioid receptor desensitization by sustained phosphorylation of serine-375. EMBO J. 2004, 23:3282-3289.
163. Selley D.E., Breivogel C.S., Childers S.R. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins. Mol. Pharmacol. 1993, 44:731-741.
164. Shannon H.E., Lutz E.A. Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats. Neuropharmacology 2002, 42:253-261.
165. Shaqura M.A., Zöllner C., Mousa S.A., Stein C., Schäfer M. Characterization of mu opioid receptor binding and G protein coupling in rat hypothalamus, spinal cord, and primary afferent neurons during inflammatory pain. J. Pharmacol. Exp. Ther. 2004, 308:712-718.
166. Silbert S.C., Beacham D.W., McCleskey E.W. Quantitative single-cell differences in mu-opioid receptor mRNA distinguish myelinated and unmyelinated nociceptors. J. Neurosci. 2003, 23:34-42.
167. Sim L.J., Selley D.E., Dworkin S.I., Childers S.R. Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain. J. Neurosci. 1996, 16:2684-2692.
168. Sitte N., Busch M., Mousa S.A., Labuz D., Rittner H., Gore C., Krause H., Stein C., Schäfer M. Lymphocytes upregulate signal sequence-encoding proopiomelanocortin mRNA and beta-endorphin during painful inflammation in vivo. J. Neuroimmunol. 2007, 183:133-145.
169. Smith E.M. Opioid peptides in immune cells. Adv. Exp. Med. Biol. 2003, 521:51-68.
170. Smith E.M., Blalock J.E. Human lymphocyte production of corticotropin and endorphin-like substances: association with leukocyte interferon. Proc. Natl. Acad. Sci. USA 1981, 78:7530-7534.
171. Smith E.M., Morrill A.C., Meyer W.J., Blalock J.E. Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. Nature 1986, 321:881-882.
172. Sorkin L.S., Moore J., Boyle D.L., Yang L., Firestein G.S. Regulation of peripheral inflammation by spinal adenosine: role of somatic afferent fibers. Exp. Neurol. 2003, 184:162-168.
173. Stander S., Gunzer M., Metze D., Luger T., Steinhoff M. Localization of mu-opioid receptor 1A on sensory nerve fibers in human skin. Regul. Pept. 2002, 110:75-83.
174. Stein C. The control of pain in peripheral tissue by opioids. N. Engl. J. Med. 1995, 332:1685-1690.
175. Stein C., Millan M.J., Shippenberg T.S., Peter K., Herz A. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J. Pharmacol. Exp. Ther. 1989, 248:1269-1275.
176. Stein C., Gramsch C., Herz A. Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin. J. Neurosci. 1990, 10:1292-1298.
177. Stein C., Hassan A.H., Przewlocki R., Gramsch C., Peter K., Herz A. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc. Natl. Acad. Sci. USA 1990, 87:5935-5939.
178. Stein C., Comisel K., Haimerl E., Yassouridis A., Lehrberger K., Herz A., Peter K. Analgesic effect of intraarticular morphine after arthroscopic knee surgery. N. Engl. J. Med. 1991, 325:1123-1126.
179. Stein C., Hassan A.H., Lehrberger K., Giefing J., Yassouridis A. Local analgesic effect of endogenous opioid peptides. Lancet 1993, 342:321-324.
180. Stein C., Pfluger M., Yassouridis A., Hoelzl J., Lehrberger K., Welte C., Hassan A.H. No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J. Clin. Invest. 1996, 98:793-799.
181. Stein A., Yassouridis A., Szopko C., Helmke K., Stein C. Intraarticular morphine versus dexamethasone in chronic arthritis. Pain 1999, 83:525-532.
182. Stein C., Machelska H., Schäfer M. Peripheral analgesic and antiinflammatory effects of opioids. Z. Rheumatol. 2001, 60:416-424.
183. Stein C., Schäfer M., Machelska H. Attacking pain at its source: new perspectives on opioids. Nat. Med. 2003, 9:1003-1008.
184. Stein C., Clark J.D., Oh U., Vasko M.R., Wilcox G.L., Overland A.C., Vanderah T.W., Spencer R.H. Peripheral mechanisms of pain and analgesia. Brain Res. Rev. 2009, 60:90-113.
185. Stephanou A., Knight R.A., De Laurenzi V., Melino G., Lightman S.L. Expression of pre-opiomelanocortin (POMC) mRNA in undifferentiated and in vitro differentiated human neuroblastoma cell lines. Prog. Clin. Biol. Res. 1991, 366:173-180.
186. Sternini C., Spann M., Anton B., Keith D.E., Bunnett N.W., von Zastrow M., Evans C., Brecha N.C. Agonist-selective endocytosis of mu opioid receptor by neurons in vivo. Proc. Natl. Acad. Sci. USA 1996, 93:9241-9246.
187. Straub R.H., Wolff C., Fassold A., Hofbauer R., Chover-Gonzalez A., Richards L.J., Jessop D.S. Antiinflammatory role of endomorphins in osteoarthritis, rheumatoid arthritis, and adjuvant-induced polyarthritis. Arthritis Rheum. 2008, 58:456-466.
188. Sung B., Loh H.H., Wei L. Association of kappa opioid receptor mRNA upregulation in dorsal root ganglia with mechanical allodynia in mice following nerve injury. Neurosci. Lett. 2000, 291:163-166.
189. Sweetnam P.M., Wrathall J.R., Neale J.H. Localization of dynorphin gene product-immunoreactivity in neurons from spinal cord and dorsal root ganglia. Neuroscience 1986, 18:947-955.
190. Szabo I., Chen X.H., Xin L., Adler M.W., Howard O.M., Oppenheim J.J., Rogers T.J. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc. Natl. Acad. Sci. USA 2002, 99:10276-10281.
191. Takahashi H., Hakamata Y., Watanabe Y., Kikuno R., Miyata T., Numa S. Complete nucleotide sequence of the human corticotropin-beta-lipotropin precursor gene. Nucleic Acids Res. 1983, 11:6847-6858.
192. Tegeder I., Geisslinger G. Opioids as modulators of cell death and survival - unraveling mechanisms and revealing new indications. Pharmacol. Rev. 2004, 56:351-369.
193. Tegeder I., Meier S., Burian M., Schmidt H., Geisslinger G., Lotsch J. Peripheral opioid analgesia in experimental human pain models. Brain 2003, 126:1092-1102.
194. Terman G.W., Shavit Y., Lewis J.W., Cannon J.T., Liebeskind J.C. Intrinsic mechanisms of pain inhibition: activation by stress. Science 1984, 226:1270-1277.
195. Truong W., Cheng C., Xu Q.G., Li X.Q., Zochodne D.W. Mu opioid receptors and analgesia at the site of a peripheral nerve injury. Ann. Neurol. 2003, 53:366-375.
196. van Dorp E.L., Morariu A., Dahan A. Morphine-6-glucuronide: potency and safety compared with morphine. Expert Opin. Pharmacother. 2008, 9:1955-1961.
197. Vanderah T.W., Schteingart C.D., Trojnar J., Junien J.L., Lai J., Riviere P.J. FE200041 (d-Phe-d-Phe-d-Nle-d-Arg-NH2): a peripheral efficacious kappa opioid agonist with unprecedented selectivity. J. Pharmacol. Exp. Ther. 2004, 310:326-333.
198. Vanderah T.W., Largent-Milnes T., Lai J., Porreca F., Houghten R.A., Menzaghi F., Wisniewski K., Stalewski J., Sueiras-Diaz J., Galyean R., Schteingart C., Junien J.L., Trojnar J., Riviere P.J. Novel d-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors. Eur. J. Pharmacol. 2008, 583:62-72.
199. Verma-Gandhu M., Bercik P., Motomura Y., Verdu E.F., Khan W.I., Blennerhassett P.A., Wang L., El-Sharkawy R.T., Collins S.M. CD4(+) T-cell modulation of visceral nociception in mice. Gastroenterology 2006, 130:1721-1728.
200. Vetter I., Kapitzke D., Hermanussen S., Monteith G.R., Cabot P.J. The effects of pH on beta-endorphin and morphine inhibition of calcium transients in dorsal root ganglion neurons. J. Pain 2006, 7:488-499.
201. Vindrola O., Mayer A.M., Citera G., Spitzer J.A., Espinoza L.R. Prohormone convertases PC2 and PC3 in rat neutrophils and macrophages. Parallel changes with proenkephalin-derived peptides induced by LPS in vivo. Neuropeptides 1994, 27:235-244.
202. von Andrian U.H., Mackay C.R. T-cell function and migration. Two sides of the same coin. N. Engl. J. Med. 2000, 343:1020-1034.
203. Walczak J.S., Pichette V., Leblond F., Desbiens K., Beaulieu P. Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: a new model of neuropathic pain. Neuroscience 2005, 132:1093-1102.
204. Wallace M.S., Moulin D., Clark A.J., Wasserman R., Neale A., Morley-Forster P., Castaigne J.P., Teichman S. A Phase II, multicenter, randomized, double-blind, placebo-controlled crossover study of CJC-1008 - a long-acting, parenteral opioid analgesic - in the treatment of postherpetic neuralgia. J. Opioid. Manag. 2006, 2:167-173.
205. Wang H., Wessendorf M.W. Equal proportions of small and large DRG neurons express opioid receptor mRNAs. J. Comp. Neurol. 2001, 429:590-600.
206. Wang J.B., Imai Y., Eppler C.M., Gregor P., Spivak C.E., Uhl G.R. Mu opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. USA 1993, 90:10230-10234.
207. Weihe E., Nohr D., Millan M.J., Stein C., Muller S., Gramsch C., Herz A. Peptide neuroanatomy of adjuvant-induced arthritic inflammation in rat. Agents Actions. 1988, 25:255-259.
208. Westly H.J., Kleiss A.J., Kelley K.W., Wong P.K., Yuen P.H. Newcastle disease virus-infected splenocytes express the proopiomelanocortin gene. J. Exp. Med. 1986, 163:1589-1594.
209. Whistler J.L., Enquist J., Marley A., Fong J., Gladher F., Tsuruda P., Murray S.R., Von Zastrow M. Modulation of postendocytic sorting of G protein-coupled receptors. Science 2002, 297:615-620.
210. Willer J.C., Dehen H., Cambier J. Stress-induced analgesia in humans: endogenous opioids and naloxone-reversible depression of pain reflexes. Science 1981, 212:689-691.
211. Woolf C.J., Salter M.W. Neuronal plasticity: increasing the gain in pain. Science 2000, 288:1765-1769.
212. Yaksh T.L. Substance P release from knee joint afferent terminals: modulation by opioids. Brain Res. 1988, 458:319-324.
213. Zhang Q., Schäfer M., Elde R., Stein C. Effects of neurotoxins and hindpaw inflammation on opioid receptor immunoreactivities in dorsal root ganglia. Neuroscience 1998, 85:281-291.
214. Zhang X., Bao L., Arvidsson U., Elde R., Hokfelt T. Localization and regulation of the delta-opioid receptor in dorsal root ganglia and spinal cord of the rat and monkey: evidence for association with the membrane of large dense-core vesicles. Neuroscience 1998, 82:1225-1242.
215. Zhang X., Bao L., Shi T.J., Ju G., Elde R., Hokfelt T. Down-regulation of mu-opioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy. Neuroscience 1998, 82:223-240.
216. Zhang X., Bao L., Guan J.S. Role of delivery and trafficking of delta-opioid peptide receptors in opioid analgesia and tolerance. Trends Pharmacol. Sci. 2006, 27:324-329.
217. Zöllner C., Stein C. Opioids. Handb. Exp. Pharmacol. 2007, 177:31-63.
218. Zöllner C., Shaqura M.A., Bopaiah C.P., Mousa S., Stein C., Schäfer M. Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol. Pharmacol. 2003, 64:202-210.
219. Zöllner C., Mousa S.A., Fischer O., Rittner H.L., Shaqura M., Brack A., Shakibaei M., Binder W., Urban F., Stein C., Schäfer M. Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain. J. Clin. Invest. 2008, 118:1065-1073.